Sloan-Kettering Institute: Research Programs

Pictured: Joan Massagué
Cancer Biology & Genetics

Learn about the Cancer Biology and Genetics Program. Our goal is to pursue research bridging basic and clinical aspects of the genesis, progression, prognosis, prevention, and treatment of cancer.

Pictured: Joan Massagué
Pictured: Alan Hall
Cell Biology

Learn about the Cell Biology Program. Our activities are directed toward understanding the molecular mechanisms that control normal cell behavior and how these are disrupted in cancer.

Pictured: Alan Hall
Pictured: Chris Sander
Computational Biology

Learn about the Computational Biology Program. Our aim is to build computer models that simulate biological processes on the molecular level to the organism as a whole and to use these models to make useful predictions.

Pictured: Chris Sander
Pictured: Kathryn Anderson
Developmental Biology

Learn about the Developmental Biology Program. Our investigators study the mechanisms that control cell proliferation, cell differentiation, tissue patterning, and tissue morphogenesis.

Pictured: Kathryn Anderson
Pictured: Alexander Rudensky
Immunology

Learn about the Immunology Program, which incorporates a wide range of basic and medical research areas. We are dedicated to translating laboratory findings into effective clinical applications.

Pictured: Alexander Rudensky
Pictured: Kenneth J. Marians
Molecular Biology

Learn about the Molecular Biology Program. Our research is directed at understanding how cell growth is regulated and how the integrity of the genome is maintained.

Pictured: Kenneth J. Marians
Pictured: David Scheinberg
Molecular Pharmacology & Chemistry

Learn about the Molecular Pharmacology and Chemistry Program, which is dedicated to bringing discoveries in the basic biological sciences to preclinical and clinical evaluation.

Pictured: David Scheinberg
Pictured: Nikola Pavletich
Structural Biology

Learn about the Structural Biology Program. Our researchers are dedicated to understanding biology at the structural and mechanistic levels, and aiding the development of new cancer therapies.

Pictured: Nikola Pavletich